[APASL2013]High-Rates of Sustained-HCV-Clearance Following 24-Weeks of Alisporivir (ALV) + Ribavirin (RBV) (+/-IFN-add-on) in HCV G2/3 Treatment-Naive Patients: Final SVR24

发表时间：2013-06-07 标签： 摘要赏析 丙肝 摘要赏析 相关搜索： ALV RBV IFN HCV